Benzbromarone market analysis of the status quo and prospects

Author:ANROSOFT_market survey report Company,market survey report services.( http://anrosoft.com )

Gout is a common Europe and the United States, are relatively rare in the East countries. However, in our country, in recent years as people’s living standards improve, patients with gout are also increasing. Huayuan Pharmaceutical Co., Ltd to provide e-commerce data shows that from 2000 to 2006, anti-gout medication hospital drugs increase the amount of linear trend. 2007 data show that the amount of hospital use in 2000 than the growth of around 13 percentage points.

Benzbromarone incalculable market potential

At present, clinical use of anti-gout drugs There are four main: colchicine, allopurinol, probenecid and benzbromarone.

Colchicine in acute attack of gout are inflammation of the strong inhibition of the drug, but often use or high doses can cause a lot of side effects; allopurinol are so far the only effective in reducing uric acid production, lower blood and urine uric acid the level of drug treatment of primary gout and its main side effects are bone marrow suppression; chronic gout drugs probenecid significantly more adverse effects, taking a large number of kidney damage and lead to kidney stone. This type of three kinds of anti-gout efficacy and toxicity of the drug because of side effects and other reasons, since 2000 the market will begin sales of a decline in varying degrees, has one of probenecid is out of the market trend.

In contrast, applications in Europe for many years with benzbromarone side effects were significantly smaller that the characteristics of our country since 2000 after entering occupied the anti-gout medication drugs first hospital position, and lead to other three kinds of drugs. Huayuan Pharmaceutical Co., Ltd. According to the data of e-commerce, 2000, benzbromarone was entered China’s market, on account of anti-gout medication hospital the amount of drugs 43.3%; in 2002, domestic enterprises listed on the generic products, making benzbromarone use of the hospital to further expand the amount of the share of 57.9 percent; that by 2007, benzbromarone has occupied the market of anti-gout medication drugs the amount of the 79.7% share, and ranked second only to the other purine accounted for 15.8%. Moreover, benzbromarone current market share is increasing its market potential can hardly be estimated.

Best advantage of imitation products

In 2007, China’s anti-gout drug market primarily by the dragon Reddy Kunshan Pharmaceutical Co., Ltd., Germany Herman large pharmaceutical companies, Hubei Pharmaceutical Co., Ltd. Dongyang Yidu three enterprises divided by total occupied the anti-pain Wind drugs market share around 70%. Among them, the biggest market share Reddy are the pharmaceutical companies. The enterprise is the first production of generic drugs Benzbromarone enterprises, so the best advantage and price advantage of up to become the leader in this field, accounting for sampling in 2007 of anti-gout drugs hospital sales of 44.4%; Germany Herman large pharmaceutical companies in second place; Dongyang Pharmaceutical Benzbromarone With the price advantage of generic drugs, a strong rise in 2007, received anti-gout drugs 10.1% market share of the hospital administration, living in the third .

In recent years, anti-gout drugs occupy a market share of several of the former town of Beijing, Guangzhou, Shanghai, the city standard of living is higher, and the apparent momentum of the South over the North medication. Beijing, Shanghai, the use of benzbromarone the highest proportion of the amount, the share of both the city and accounted for drug benzbromarone 60% of the market. At Guangzhou, anti-gout drug consumption more evenly varieties, four kinds of drugs near the more sales.

Star drug benzbromarone wavy trend of the drug, the larger seasonal fluctuations, use a low ebb for the first quarter of each year, the peak period for many third and fourth quarters. Benzbromarone market has the form capsules, tablets two tablets in one of the leading position.

At present, our country gout patients continues to grow, and to show the trend of the spread of a younger age, so anti-gout drugs in our country a great potential market, but the market on anti-gout drugs for many older drugs, generic drugs , but side effects cheap obviously, if there is a timely introduction of new drugs, the market outlook is considerable.

Related analysis market survey Report >>

• Countries in the development of alternatives to plastic bags Investigation and Analysis
• Polysilicon industry market research analysis
• China Alumina Industry Review and Analysis
• Market research analysis of ceramic fiber
• plastic pipe industry, prospects for the development of analysis
• New type of gypsum board market analysis and investigate the prospects for prediction
• Japanese circuit board investigate the development of the market analysis
• Solar power, LED industry growth good
• Top Ten in 2008 predicted that the semiconductor industry
• Voice of Chinese electricity industry trends and market research analysis
• Development Trend of China’s timber industry and market research analysis
• China’s polysilicon industry market research analysis of the future
• The advantages and disadvantages of glass curtain wall
• China’s glass fiber industry market research analysis
• Chinese flexible packaging market research analysis

Contact us,I’m
Online!